Coeptis enters sponsored research agreement with Univ. of Pittsburgh for SNAP-CAR HER2 pre-clinical work

Z Squared Inc.

Sponsored research agreement with University of Pittsburgh to advance SNAP-CAR T cells targeting HER2-positive cancers.
Pre-clinical work will support IND filing for clinical trials, initially targeting ovarian cancer.
Research led by Dr. Lohmueller and Dr. Deiters; IQVIA to assist as CRO for lead candidate selection.
HER2 overexpressed in ~28% of ovarian cancer and ~25% of breast cancer cases, per the press release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.